Elsevier Inc.

SHERPA: Unknown

People

  1. De Stanchina
    De Stanchina
  2. Rudin
    Rudin
  3. Powell
    Powell
  4. Riaz
    Riaz
  5. Shah
    Shah

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Department of Medicine (4)
  3. GSK Faculty (4)
  4. Solid Tumor Oncology Division (4)
  5. Thoracic Oncology (4)
  6. Sloan Kettering Institute Postdocs (2)
  7. Radiation Oncology, Department of (1)
  8. Radiochemistry and Imaging Sciences Service (1)
  9. Radiology, Department of (1)
Search Within
  1. "Charles Rudin"
  2. "John Poirier"
  3. "International Journal of Radiation Oncology, Biology, Physics"
Formats
  1. Meeting Abstract (4)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Department of Medicine (4)
  3. GSK Faculty (4)
  4. Solid Tumor Oncology Division (4)
  5. Thoracic Oncology (4)
  6. Sloan Kettering Institute Postdocs (2)

More Groups

People
  1. Charles Rudin (4)
  2. John Poirier (4)
  3. Elisa De Stanchina (3)
  4. Andrew Bell (2)
  5. Benjamin Lok (2)
  6. James Laird (2)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (1)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PARP trapping by talazoparib is a potent mechanism of radiosensitization in small cell lung cancer cell lines and patient-derived xenografts
    Meeting Abstract

    Laird, J. H. Jr; Lok, B. H.; Ma, J.; Bell, A.; De Stanchina, E.; Poirier, J.; Rudin, C. M.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • [(18)F]PARPi PET as a marker of intratumoral talazoparib level in small cell lung cancer
    Meeting Abstract

    Laird, J. H.; Lok, B. H.; Carney, B.; Kossatz, S.; Ma, J.; Bell, A.; Shah, N.; Sadique, A.; De Stanchina, E.; Reiner, T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX)
    Meeting Abstract

    Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Epigenetic analysis of small cell lung cancer defines distinct disease subsets
    Meeting Abstract

    Rudin, C. M.; Connis, N.; Hann, C. L.; Poirier, J. T.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save